CytomX Therapeutics
We posted several articles that brought good news from CytomX Therapeutics (CTMX), yet the stock continues to go down instead of up. A few days ago, CytomX announced the achievement of a clinical candidate milestone under its agreement with Astellas.
The clinical . . .
This content is for paid subscribers.
Impacting News
February 2, 2023
